Lipid/Polymer Nanoformulations with Alphavirus Replicon RNA
Exclusively Licensed
Invention type: Technology
/
Case number: #17996H
Disclosed herein are lipid nanoparticles comprising 1,2-dioleoyl-3-trimethylammonium propane (DOTAP), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000](DSPE-PEG2000), compositions including such lipid nanoparticles, and methods of treatment using such lipid nanoparticles and compositions.
Researchers
Darrell J Irvine
/
Yuan Zhang
/
Mariane Melo
/
Tasuku Kitada
/
Ron Weiss
Departments: Department of Biological Engineering
Technology Areas: Biotechnology: DNA & RNA Editing, Synthetic Biology / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Nucleic Acids, Vaccines
Impact Areas: Healthy Living
-
lipid nanoparticles and use thereof to deliver rna polynucleotides
United States of America | Granted | 11,026,894
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.